Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • chouf
    Junior Member
    • Jul 2012
    • 2

    Solid Mapping

    hello,

    I would like to know, When you have reads about 35/50 Bp, And you want to see if the gene is expressed or not.

    How many reads must have it to show that the gene is expressed?

    Thanks

    Chouf
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    One high "mapability" read (i.e. "it really does go to that location") is evidence that that gene is expressed.

    Comment

    • chouf
      Junior Member
      • Jul 2012
      • 2

      #3
      So for example on this pictures, you have a gene expressed or not?

      May be there is an average of reads?

      thanks
      Attached Files

      Comment

      • mbblack
        Senior Member
        • Aug 2009
        • 245

        #4
        Originally posted by chouf View Post
        So for example on this pictures, you have a gene expressed or not?

        May be there is an average of reads?

        thanks
        I'm not sure if you are thinking of two different things. If you mean is a gene detected, that is was it expressed in the sampled mRNA pool, then a single unique mapped read would answer yes. As long as your mapping stringency was high (a reasonable read QV cutoff and a mapping score QV cutoff).

        Would you want to base actual estimated expression levels off such genes, as in a differential gene expression analyssis? No, I would say not. In the literature, you will find people using some minimum mapped read count for inclusion in their esitmations of expression levels. So, only genes having a minimum number of uniquely mapped reads of say, greater than 5 or greater than 10 are common numbers (or so is my take from published analyses).

        So there are two questions.

        1. Was a gene/transcript/feature detected at all - basically presence or absence of a mappable feature?
        2. Which genes have sufficient reads to provide reliable estimates of relative expression?

        For 1. again if you set up your mapping well (read QV stringency and mapping QV stringency), then even a single unique mapped read is evidence for the detection of a gene or transcript.

        For 2. I would not be comfortable actually using any genes with fewer than 10 mapped reads in any relative expression estimates (since this is now a question of having enough data to confidently estimate an actual level of expression, not merely the presence or absence of a feature).
        Michael Black, Ph.D.
        ScitoVation LLC. RTP, N.C.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 12:17 PM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...